Division of Pediatric Infectious Diseases

July 28, 2022

Study to evaluate nasal flu vaccine for children

Pediatricians with the Vanderbilt Vaccine Research Program are looking for healthy infants and children (6 months – 8 years of age) to take part in a nasal influenza vaccine study.

By Craig Boerner
Jim Cassat, MD, PhD, and colleagues are studying enzymes involved in metabolism that are particularly important for Staphylococcus aureus to survive in host tissues.
July 7, 2022

Mathers Foundation award supports study of crosstalk between skeletal, immune systems

Vanderbilt’s Jim Cassat, MD, PhD, has received a three-year, $750,000 award from the G. Harold and Leila Y. Mathers Foundation to support research exploring the interplay between bone homeostasis and infectious disease.

By Leigh MacMillan
July 6, 2022

Study shows two vaccine doses for mothers eases COVID complications for infants

Infants younger than 6 months were better protected from COVID-19 complications when mothers received two doses of the vaccine while pregnant, according to Vanderbilt researchers.

By Jessica Pasley
June 16, 2022

VUMC research aids approval of COVID-19 vaccine for young children

The U.S. Food and Drug Administration is expected to authorize Pfizer and Moderna’s COVID-19 vaccines for children as young as 6 months old as early as tomorrow, following the unanimous recommendation by an FDA advisory panel on Wednesday.

By Bill Snyder
Dolly Parton and longtime friend, Naji Abumrad, MD. (photo Courtesy of Dolly Parton)
June 15, 2022

Dolly Parton donates $1 million to pediatric infectious disease research at Vanderbilt University Medical Center

Dolly Parton is donating $1 million to pediatric infectious disease research at Vanderbilt University Medical Center to help in the fight against serious infectious diseases such as coronavirus that have worldwide ramifications.

By Craig Boerner
May 12, 2022

VUMC-led study finds Moderna COVID vaccine safe and effective for children

By Bill Snyder
May 10, 2022

Resistance to COVID-19 drug detected in lab study

Vanderbilt research shows that the virus that causes COVID-19 can develop partial resistance to the antiviral drug remdesivir during infection of cultured cells in the laboratory by more than one mechanism.  
By Bill Snyder
March 30, 2022

Uncharted days of the COVID-19 pandemic strengthen the Vanderbilt Vaccine Research Program team.

“There’s something about having a band of brothers, where you’re all focused on the same thing, and your noses are all pointed in the same direction."
By Jill Clendening
March 7, 2022

Teen shares his battle with MIS-C following COVID-19 infection

Reeyan Ahmed is among the patients treated at Monroe Carell Jr. Children's Hospital at Vanderbilt who developed MIS-C following COVID-19 infection.
By Christina Echegaray
February 24, 2022

MIS-C diagnosis rare in vaccinated children with no previous COVID-19 diagnosis

A Vanderbilt study found that children who received the COVID-19 vaccine who had not previously been diagnosed with COVID infection are unlikely to be diagnosed with multisystem inflammatory syndrome in children (MIS-C).
By Kylie Avery
February 17, 2022

VUMC recognized for antimicrobial drug stewardship efforts

By Paul Govern
February 3, 2022

Study finds shorter treatment better for young children with outpatient pneumonia

A Vanderbilt study found that five days of antibiotics is superior to 10 days for children with community-acquired pneumonia who are not hospitalized.
By Craig Boerner
January 6, 2022

New faculty awards honor clinical, research, teaching missions

The Office of Research, the Office of Faculty Affairs, and the Basic Sciences have created four new faculty awards named to honor and recognize past and current leadership in the clinical, educational, and research missions of Vanderbilt University School of Medicine.
By VUMC News and Communications
1 2 3 4 5 … 11